New-onset cutaneous lichen planus following Vaxzevria (Oxford-AstraZeneca) COVID-19 vaccination
We report a 56-year-old male who developed cutaneous lichen planus (LP) following Vaxzevria (Oxford-AstraZeneca) COVID-19 vaccination. Multiple topical and systemic therapies were tried with limited success; however, partial improvement was observed with narrow-band UVB (NB-UVB) phototherapy. This r...
| Главные авторы: | , , |
|---|---|
| Формат: | Статья |
| Язык: | English |
| Опубликовано: |
SAGE Publishing
2024-12-01
|
| Серии: | SAGE Open Medical Case Reports |
| Online-ссылка: | https://doi.org/10.1177/2050313X241307109 |
| _version_ | 1826926254304002048 |
|---|---|
| author | Amira Muftah Stephen Lee Mariam Abbas |
| author_facet | Amira Muftah Stephen Lee Mariam Abbas |
| author_sort | Amira Muftah |
| collection | DOAJ |
| description | We report a 56-year-old male who developed cutaneous lichen planus (LP) following Vaxzevria (Oxford-AstraZeneca) COVID-19 vaccination. Multiple topical and systemic therapies were tried with limited success; however, partial improvement was observed with narrow-band UVB (NB-UVB) phototherapy. This report adds to the growing evidence of new-onset LP following COVID-19 vaccination and underscores the need for careful reporting, monitoring, and management of vaccine-related adverse effects. |
| first_indexed | 2025-02-17T15:08:31Z |
| format | Article |
| id | doaj.art-8df631b9c4f94e7c981f989a5c7d9ac6 |
| institution | Directory Open Access Journal |
| issn | 2050-313X |
| language | English |
| last_indexed | 2025-02-17T15:08:31Z |
| publishDate | 2024-12-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | SAGE Open Medical Case Reports |
| spelling | doaj.art-8df631b9c4f94e7c981f989a5c7d9ac62024-12-20T13:03:19ZengSAGE PublishingSAGE Open Medical Case Reports2050-313X2024-12-011210.1177/2050313X241307109New-onset cutaneous lichen planus following Vaxzevria (Oxford-AstraZeneca) COVID-19 vaccinationAmira Muftah0Stephen Lee1Mariam Abbas2Department of Dermatology, College of Medicine, University of Calgary, Calgary, AB, CanadaDepartment of Infectious Diseases, College of Medicine, University of Saskatchewan, Regina, SK, CanadaDepartment of Dermatology, College of Medicine, University of Saskatchewan, Regina, SK, CanadaWe report a 56-year-old male who developed cutaneous lichen planus (LP) following Vaxzevria (Oxford-AstraZeneca) COVID-19 vaccination. Multiple topical and systemic therapies were tried with limited success; however, partial improvement was observed with narrow-band UVB (NB-UVB) phototherapy. This report adds to the growing evidence of new-onset LP following COVID-19 vaccination and underscores the need for careful reporting, monitoring, and management of vaccine-related adverse effects.https://doi.org/10.1177/2050313X241307109 |
| spellingShingle | Amira Muftah Stephen Lee Mariam Abbas New-onset cutaneous lichen planus following Vaxzevria (Oxford-AstraZeneca) COVID-19 vaccination SAGE Open Medical Case Reports |
| title | New-onset cutaneous lichen planus following Vaxzevria (Oxford-AstraZeneca) COVID-19 vaccination |
| title_full | New-onset cutaneous lichen planus following Vaxzevria (Oxford-AstraZeneca) COVID-19 vaccination |
| title_fullStr | New-onset cutaneous lichen planus following Vaxzevria (Oxford-AstraZeneca) COVID-19 vaccination |
| title_full_unstemmed | New-onset cutaneous lichen planus following Vaxzevria (Oxford-AstraZeneca) COVID-19 vaccination |
| title_short | New-onset cutaneous lichen planus following Vaxzevria (Oxford-AstraZeneca) COVID-19 vaccination |
| title_sort | new onset cutaneous lichen planus following vaxzevria oxford astrazeneca covid 19 vaccination |
| url | https://doi.org/10.1177/2050313X241307109 |
| work_keys_str_mv | AT amiramuftah newonsetcutaneouslichenplanusfollowingvaxzevriaoxfordastrazenecacovid19vaccination AT stephenlee newonsetcutaneouslichenplanusfollowingvaxzevriaoxfordastrazenecacovid19vaccination AT mariamabbas newonsetcutaneouslichenplanusfollowingvaxzevriaoxfordastrazenecacovid19vaccination |